Stock Track | Sotera Health Plummets 5.03% Intraday on Q4 Pretax Profit Miss and 2026 Guidance

Stock Track02-25

Sotera Health Company's stock plummeted 5.03% during intraday trading on Tuesday, following the release of its fourth-quarter 2025 financial results and 2026 outlook.

The company reported a Q4 pretax profit of $70.5 million, which fell short of the IBES estimate of $96.4 million. This miss appears to be a primary driver behind the stock's decline. For the full year 2026, Sotera Health provided adjusted EPS guidance in the range of $0.93 to $1.01, which aligns closely with the FactSet consensus estimate of $0.94.

While the company delivered a revenue beat for Q4 and showed year-over-year growth, the significant shortfall in pretax profit compared to analyst expectations likely prompted a negative market reaction during the session.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment